vs

Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.

APOGEE ENTERPRISES, INC. is the larger business by last-quarter revenue ($351.4M vs $209.6M, roughly 1.7× Varex Imaging Corp). APOGEE ENTERPRISES, INC. runs the higher net margin — 4.7% vs 1.1%, a 3.6% gap on every dollar of revenue. On growth, Varex Imaging Corp posted the faster year-over-year revenue change (4.9% vs 1.6%). Over the past eight quarters, APOGEE ENTERPRISES, INC.'s revenue compounded faster (2.9% CAGR vs 0.8%).

Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.

Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.

APOG vs VREX — Head-to-Head

Bigger by revenue
APOG
APOG
1.7× larger
APOG
$351.4M
$209.6M
VREX
Growing faster (revenue YoY)
VREX
VREX
+3.3% gap
VREX
4.9%
1.6%
APOG
Higher net margin
APOG
APOG
3.6% more per $
APOG
4.7%
1.1%
VREX
Faster 2-yr revenue CAGR
APOG
APOG
Annualised
APOG
2.9%
0.8%
VREX

Income Statement — Q4 FY2026 vs Q1 FY2026

Metric
APOG
APOG
VREX
VREX
Revenue
$351.4M
$209.6M
Net Profit
$16.6M
$2.3M
Gross Margin
22.4%
33.3%
Operating Margin
7.3%
7.3%
Net Margin
4.7%
1.1%
Revenue YoY
1.6%
4.9%
Net Profit YoY
568.8%
866.7%
EPS (diluted)
$0.78
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APOG
APOG
VREX
VREX
Q1 26
$351.4M
$209.6M
Q4 25
$348.6M
$228.9M
Q3 25
$358.2M
$203.0M
Q2 25
$346.6M
$212.9M
Q1 25
$345.7M
$199.8M
Q4 24
$341.3M
Q3 24
$342.4M
$205.7M
Q2 24
$331.5M
$209.1M
Net Profit
APOG
APOG
VREX
VREX
Q1 26
$16.6M
$2.3M
Q4 25
$16.5M
$12.2M
Q3 25
$23.6M
$-89.1M
Q2 25
$-2.7M
$6.9M
Q1 25
$2.5M
$-300.0K
Q4 24
$21.0M
Q3 24
$30.6M
$-51.1M
Q2 24
$31.0M
$1.4M
Gross Margin
APOG
APOG
VREX
VREX
Q1 26
22.4%
33.3%
Q4 25
23.8%
34.0%
Q3 25
23.1%
33.3%
Q2 25
21.7%
36.0%
Q1 25
21.6%
34.3%
Q4 24
26.1%
Q3 24
28.4%
32.6%
Q2 24
29.8%
32.0%
Operating Margin
APOG
APOG
VREX
VREX
Q1 26
7.3%
7.3%
Q4 25
7.1%
8.6%
Q3 25
7.5%
-39.8%
Q2 25
2.0%
10.4%
Q1 25
1.8%
5.6%
Q4 24
8.4%
Q3 24
12.3%
5.3%
Q2 24
12.5%
4.4%
Net Margin
APOG
APOG
VREX
VREX
Q1 26
4.7%
1.1%
Q4 25
4.7%
5.3%
Q3 25
6.6%
-43.9%
Q2 25
-0.8%
3.2%
Q1 25
0.7%
-0.2%
Q4 24
6.1%
Q3 24
8.9%
-24.8%
Q2 24
9.4%
0.7%
EPS (diluted)
APOG
APOG
VREX
VREX
Q1 26
$0.78
$0.05
Q4 25
$0.77
$0.29
Q3 25
$1.10
$-2.15
Q2 25
$-0.13
$0.17
Q1 25
$0.12
$-0.01
Q4 24
$0.96
Q3 24
$1.40
$-1.25
Q2 24
$1.41
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APOG
APOG
VREX
VREX
Cash + ST InvestmentsLiquidity on hand
$39.5M
$125.6M
Total DebtLower is stronger
$232.3M
$367.6M
Stockholders' EquityBook value
$511.8M
$476.9M
Total Assets
$1.1B
$1.1B
Debt / EquityLower = less leverage
0.45×
0.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APOG
APOG
VREX
VREX
Q1 26
$39.5M
$125.6M
Q4 25
$41.3M
$155.1M
Q3 25
$39.5M
$152.6M
Q2 25
$32.8M
$223.0M
Q1 25
$41.4M
$212.6M
Q4 24
$43.9M
Q3 24
$51.0M
$200.5M
Q2 24
$30.4M
$190.0M
Total Debt
APOG
APOG
VREX
VREX
Q1 26
$232.3M
$367.6M
Q4 25
$367.5M
Q3 25
$367.5M
Q2 25
$567.2M
Q1 25
$285.0M
$567.0M
Q4 24
Q3 24
$443.4M
Q2 24
$443.1M
Stockholders' Equity
APOG
APOG
VREX
VREX
Q1 26
$511.8M
$476.9M
Q4 25
$512.3M
$472.6M
Q3 25
$500.2M
$455.3M
Q2 25
$481.8M
$549.7M
Q1 25
$487.9M
$540.2M
Q4 24
$522.1M
Q3 24
$506.4M
$529.1M
Q2 24
$480.0M
$581.2M
Total Assets
APOG
APOG
VREX
VREX
Q1 26
$1.1B
$1.1B
Q4 25
$1.1B
$1.1B
Q3 25
$1.2B
$1.1B
Q2 25
$1.2B
$1.4B
Q1 25
$1.2B
$1.3B
Q4 24
$1.2B
Q3 24
$917.1M
$1.2B
Q2 24
$889.0M
$1.3B
Debt / Equity
APOG
APOG
VREX
VREX
Q1 26
0.45×
0.77×
Q4 25
0.78×
Q3 25
0.81×
Q2 25
1.03×
Q1 25
0.58×
1.05×
Q4 24
Q3 24
0.84×
Q2 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APOG
APOG
VREX
VREX
Operating Cash FlowLast quarter
$122.5M
$-16.1M
Free Cash FlowOCF − Capex
$-26.8M
FCF MarginFCF / Revenue
-12.8%
Capex IntensityCapex / Revenue
7.8%
5.1%
Cash ConversionOCF / Net Profit
7.37×
-7.00×
TTM Free Cash FlowTrailing 4 quarters
$-13.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APOG
APOG
VREX
VREX
Q1 26
$122.5M
$-16.1M
Q4 25
$29.3M
$7.9M
Q3 25
$57.1M
$7.7M
Q2 25
$-19.8M
$16.6M
Q1 25
$30.0M
$9.5M
Q4 24
$31.0M
Q3 24
$58.7M
$25.9M
Q2 24
$5.5M
$8.0M
Free Cash Flow
APOG
APOG
VREX
VREX
Q1 26
$-26.8M
Q4 25
$22.9M
$2.3M
Q3 25
$52.4M
$1.4M
Q2 25
$-26.9M
$9.8M
Q1 25
$19.1M
$5.3M
Q4 24
$22.0M
Q3 24
$50.2M
$19.9M
Q2 24
$-1.8M
$3.3M
FCF Margin
APOG
APOG
VREX
VREX
Q1 26
-12.8%
Q4 25
6.6%
1.0%
Q3 25
14.6%
0.7%
Q2 25
-7.8%
4.6%
Q1 25
5.5%
2.7%
Q4 24
6.4%
Q3 24
14.7%
9.7%
Q2 24
-0.5%
1.6%
Capex Intensity
APOG
APOG
VREX
VREX
Q1 26
7.8%
5.1%
Q4 25
1.9%
2.4%
Q3 25
1.3%
3.1%
Q2 25
2.1%
3.2%
Q1 25
3.2%
2.1%
Q4 24
2.6%
Q3 24
2.5%
2.9%
Q2 24
2.2%
2.2%
Cash Conversion
APOG
APOG
VREX
VREX
Q1 26
7.37×
-7.00×
Q4 25
1.77×
0.65×
Q3 25
2.41×
Q2 25
2.41×
Q1 25
12.08×
Q4 24
1.48×
Q3 24
1.92×
Q2 24
0.18×
5.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APOG
APOG

Architectural Services$127.1M36%
Architectural Metals$110.0M31%
Architectural Glass$67.4M19%
Performance Surfaces$54.3M15%

VREX
VREX

Medical Segment$144.8M69%
Industrial Segment$64.8M31%

Related Comparisons